No Detail Found!

Retrospective Analysis of Chinese Patients with Hepatocellular Carcinoma (HCC) undergoing Transcatheter Arterial Chemoembolization (TACE) with or without Prophylactic Antibiotic Therapy.

Author(s)
Jiu Chen Affliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Guolin Wu Affliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Abstract
Objective: To assess the necessity of prophylactic antibiotic therapy in HCC patients undergoing transcatheter arterial chemoembolization (TACE). Study Design: Descriptive study. Place and Duration of Study: The First Affliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China, from August 2016 to August 2017. Methodology: Retrospective TACE-treated cases were analysed in this study. The basic characteristics of the patients, the days in hospital, the laboratory data and fever after the procedure were assessed and compared. A review of literature of published studies and our present study were further conducted to determine the necessity of prophylactic antibiotic therapy. Results: In 159 cases, there were no significant difference in the leukocyte count (p=0.552), neutrophil count (p=0.573) and fever (p=0.31) with and without prophylactic antibiotic therapy groups. The hospital stay was significantly increased in the prophylactic antibiotic group (p<0.001). The fever of previous and the present results showed no significant difference (p=0.25) between the groups. Conclusion: Prophylactic antibiotic therapy is not routinely necessary in the procedure of TACE for HCC patients.
Publication Details
Page(s) 914-918
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 12, Year: 2018

Request the full text from PASTIC

References
FerlayJ, 2015.Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012,Int J Cancer 136 E359 -86
LlovetJM,RealMI,MontañaX, 2002.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial,Lancet 359 1734 -9
LvF,LuD,HeYS,XiaoJK,ZhouCZ,ChengDL, 2016.Liver abscess formation following transarterial chemoembolization: Clinical features, risk factors, bacteria spectrum, and percutaneous catheter drainage,Medicine 95 e3503 -
TaslakianB,SridharD, 2017.Post-procedural care in interventional radiology: What every interventional radiologist should knowPart I: Standard post-procedural instructions and follow-up care,Cardiovasc Intervent Radiol 40 481 -95
LiYJ,LiGW,HuangXF,ZengQA., 2016.Clinical significance of antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: A meta- analysis,Chin Arch Gen Surg (Electronic Edition) 10 231 -4
PlentzRR,LankischTO,BastürkM., 2005.Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy,J Gastroenterol Hepatol 20 1134 -6
GaoF,ZhangXN,ChenMZ,QianT,MaAY,YinHB, 2013.Prophylactic use of antibiotics after interventional procedures for primary hepatocellular carcinoma: Its clinical significance,J Intervent Radiol 22 151 -3
ZhuWY,LiuJY,ZhouYH,LiuL,FengS,GaoB, 2014.Discussion of prophylactic use of antibiotics in interventional procedures for primary hepatocellular carcinoma,Shandong Medi J 54 59 -61
ShaoJY,ChangCL,WuSY, 2015.Statin-based palliative therapy for hepatocellular carcinoma,Medicine (Baltimore) 94 e1801 -
LiF,GuoZ,WangH, 2013.Influencing elements and treatment strategies associated with the relapse of hepatocellular carcinoma after surgery,Hepatogastroenterology 60 1148 -55
LiKW,LiX,WenTF,LuWS, 2013.The effect of postoperative TACE on prognosis of HCC: An update,Hepatogastroenterology 60 248 -51
ReedRA,TeitelbaumGP,DanielsJR, 1994.Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics,J Vasc Interv Radiol 5 367 -71
DarraghFH,WilliamCT, 2011.The infectious complications of interventional radiology based procedures in gastroenterology and hepatology,J Gastrointestin Liver Dis 20 71 -5
XiaJL,RenZG,YeSL, 2006.Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer,Eur J Radiol 59 407 -12
TarazovPG,PolysalovVN,ProzorovskijKV,GrishchenkovaIV,RozengauzEV, 2000.Ischemic complications of transcatheter arterial chemoembolization in liver malignancies,Acta Radiol 41 156 -60
HuangSF,KoCW,ChangCS,ChenGH, 2003.Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor,Hepatogastroenterology 50 1115 -8
de BaereT,RocheA,AmenabarJM,LagrangeC,DucreuxM,RougierP, 1996.Liver abscess formation after local treatment of liver tumors,Hepatology 23 1436 -40
EbisutaniC,SatoS,NishiK,InoueH,YoshieT,KinoshitaY., 2010.Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: An open randomized prospective study of oral versus intravenous administration,Intern Med 49 1059 -65
ZhengPF,ZhangJS, 2007.The meta analysis of recent complications after the interventional therapy in the advanced hepatocellular carcinoma patients,Shanghai J Prevent Med 19 517 -9
FiorentiniG,AlibertiC,TilliM,MulazzaniL,GrazianoF,PaoloG, 2012.Intra-arterial infusion of irinotecan-loaded drug-elutin beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase study,Anticancer Res 32 1387 -95
0

Citations

0

Downloads

56

Views